A pioneering 'living' knee replacement, dubbed NOVAKnee, is moving closer to human application. Developed by researchers at Columbia University and the University of Missouri, this innovative implant utilizes a biodegradable scaffold infused with stem cells to regenerate bone and cartilage. Unlike traditional metal and plastic prosthetics, NOVAKnee is designed to gradually integrate with the patient's body, potentially offering a permanent solution.
This technology holds particular promise for younger patients who often outlive conventional implants, leading to the need for revision surgeries. The NOVAKnee aims to eliminate this cycle by allowing the body to regenerate its own joint tissue. Preclinical studies are progressing, with human trials targeted within the next 18-24 months, offering hope for a revolutionary advancement in orthopedic care.
